Early-onset candidemia: An increasing problem?

Critical Care Medicine

Volumn 37, Issue 9, 2009, Pages 2652-2653

  Corona, Alberto ^a   Singer, Mervyn ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Bloodstream infection; Candidemia; Epidemiology outcome; Intensive care unit

Indexed keywords

ANTIFUNGAL AGENT; FLUCONAZOLE;

ANTIMICROBIAL THERAPY; BLOODSTREAM INFECTION; CANDIDA; CANDIDEMIA; DISEASE SEVERITY; EDITORIAL; HIGH RISK PATIENT; HOSPITAL CARE; HOSPITAL DISCHARGE; HOSPITAL READMISSION; HUMAN; INFECTION RATE; INFECTION RISK; MORBIDITY; MORTALITY; PRIORITY JOURNAL; SEROEPIDEMIOLOGY;

EID: 69349101685     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e3181abf8e6     Document Type: Editorial

References (15)

1. Shorr AF, Gupta V, Sun X, et al: Burden of early-onset candidemia: Analysis of culture-positive bloodstream infections from a large U.S. database. Crit Care Med 2009; 37: 2519-2526
2. Eggimann P, Garbino J, Pittet D: Epidemiology of Candida species infections in critically ill non-immunosuppressed patients. Lancet Infect Dis 2003; 3:685-702 (Pubitemid 37345347)
3. Morgan J, Meltzer MI, Plikaytis BD, et al: Excess mortality, hospital stay, and cost due to candidemia: a case-control study using data from population-based candidemia surveillance. Infect Control Hosp Epidemiol 2005; 26:540-547 (Pubitemid 40896144)
4. Colombo AL, Guimaraes T, Silva LR, et al: Prospective observational study of candidemia in Sao Paulo, Brazil: incidence rate, epidemiology, and predictors of mortality. Infect Control Hosp Epidemiol 2007; 28: 570-576 (Pubitemid 46814547)
5. Hajjeh RA, Sofair AN, Harrison LH, et al: Incidence of bloodstream infections due to Candida species and in vitro susceptibilities of isolates collected from 1998 to 2000 in a population-based active surveillance program. J Clin Microbiol 2004; 42:1519-1527
6. Falagas ME, Apostolou KE, Pappas VD: Attributable mortality of candidemia: a systematic review of matched cohort and case-control studies. Eur J Clin Microbiol Infect Dis 2006; 25:419-425
7. Kung HC, Wang JL, Chang SC, et al: Community-onset candidemia at a university hospital, 1995-2005. J Microbiol Immunol Infect 2007; 40:355-363
8. Sofair AN, Lyon GM, Huie-White S, et al: Epidemiology of community-onset candidemia in Connecticut and Maryland. Clin Infect Dis 2006; 43:32-39 (Pubitemid 43939073)
9. Johannes RS: Epidemiology of early-onset bloodstream infection and implications for treatment. Am J Infect Control 2008; 36: S171.e13-e17
10. Macphail GL, Taylor GD, Buchanan-Chell M, et al: Epidemiology, treatment and outcome of candidemia: a five-year review at three Canadian hospitals. Mycoses 2002; 45:141-145 (Pubitemid 34743916)
11. Pfaller MA, Diekema DJ, Jones RN, et al: International surveillance of bloodstream infections due to Candida species: frequency of occurrence and in vitro susceptibilities to fluconazole, ravuconazole, and voriconazole of isolates collected from 1997 through 1999 in the SENTRY antimicrobial surveillance program. J Clin Microbiol 2001; 39: 3254-3259
12. Richet H, Roux P, Des Champs C, et al: Candidemia in French hospitals: incidence rates and characteristics. Clin Microbiol Infect 2002; 8:405-412 (Pubitemid 34993817)
13. Diekema DJ, Messer SA, Brueggemann AB, et al: Epidemiology of candidemia: 3-year results from the emerging infections and the epidemiology of Iowa organisms study. J Clin Microbiol 2002; 40:1298-1302
14. Alonso-Valle H, Acha O, García-Palomo JD, et al: Candidemia in a tertiary care hospital: epidemiology and factors influencing mortality. Eur J Clin Microbiol Infect Dis 2003; 22:254-257 (Pubitemid 36578913)
15. Miller PJ, Wenzel RP: Etiologic organisms as independent predictors of death and morbidity associated with bloodstream infections. J Infect Dis 1987; 156:471-477